📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Modified recombinant human IgG1-Fc is superior to natural intravenous immunoglobulin at inhibiting immune-mediated demyelination. (2021)

First Author: Baksmeier C
Attributed to:  Core Support for Collaborative Research in Glycobiology funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/imm.13341

PubMed Identifier: 33880776

Publication URI: http://europepmc.org/abstract/MED/33880776

Type: Journal Article/Review

Volume: 164

Parent Publication: Immunology

Issue: 1

ISSN: 0019-2805